Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Entera Bio Ltd (NASDAQ: ENTX) closed the day trading at $1.74 down -1.14% from the previous closing price of $1.76. In other words, the price has decreased by -$1.14 from its previous closing price. On the day, 0.13 million shares were traded. ENTX stock price reached its highest trading level at $1.815 during the session, while it also had its lowest trading level at $1.74.
Ratios:
For a better understanding of ENTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.83 and its Current Ratio is at 10.83. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In the most recent recommendation for this company, Aegis Capital on March 22, 2021, initiated with a Buy rating and assigned the stock a target price of $12.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ENTX now has a Market Capitalization of 79791600 and an Enterprise Value of 71428600. For the stock, the TTM Price-to-Sale (P/S) ratio is 664.94 while its Price-to-Book (P/B) ratio in mrq is 5.22. Its current Enterprise Value per Revenue stands at 576.037 whereas that against EBITDA is -6.62.
Stock Price History:
The Beta on a monthly basis for ENTX is 1.77, which has changed by -0.18139535 over the last 52 weeks, in comparison to a change of 0.14446163 over the same period for the S&P500. Over the past 52 weeks, ENTX has reached a high of $3.22, while it has fallen to a 52-week low of $1.50. The 50-Day Moving Average of the stock is -27.91%, while the 200-Day Moving Average is calculated to be -15.93%.
Shares Statistics:
Over the past 3-months, ENTX traded about 166.87K shares per day on average, while over the past 10 days, ENTX traded about 149530 shares per day. A total of 45.66M shares are outstanding, with a floating share count of 34.70M. Insiders hold about 24.32% of the company’s shares, while institutions hold 20.05% stake in the company. Shares short for ENTX as of 1764288000 were 103037 with a Short Ratio of 0.62, compared to 1761868800 on 196467. Therefore, it implies a Short% of Shares Outstanding of 103037 and a Short% of Float of 0.26.
Earnings Estimates
Entera Bio Ltd (ENTX) is currently under the scrutiny of 1.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.11, with high estimates of -$0.11 and low estimates of -$0.11.
Analysts are recommending an EPS of between -$0.28 and -$0.28 for the fiscal current year, implying an average EPS of -$0.28. EPS for the following year is -$0.68, with 1.0 analysts recommending between -$0.68 and -$0.68.
Revenue Estimates
A total of 1 analysts have provided revenue estimates for ENTX’s current fiscal year. The highest revenue estimate was $42k, while the lowest revenue estimate was $42k, resulting in an average revenue estimate of $42k. In the same quarter a year ago, actual revenue was $181k
